The company was established in Europe in Germany. The leading representative office of defined Corporate Investor is situated in the Munich.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the EIT Health, startups are often financed by Venture Kick, MassChallenge, Horizon 2020. The meaningful sponsors for the fund in investment in the same round are Torret Road Capital, Techstars, Nina Capital. In the next rounds fund is usually obtained by Horizon 2020, EASME - EU Executive Agency for SMEs, SBRI Healthcare.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AVX Pharma, GlyCardial Diagnostics, Inovus Medical The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Life Science, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Spain.
The usual things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is generally included in 7-12 deals every year. Speaking about the real fund results, this Corporate Investor is 12 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The important activity for fund was in 2018. When the investment is from EIT Health the average startup value is 1-5 millions dollars.
|AMS INDUSTRIES||France, Ile-de-France, Paris|
|Beechtree Capital||New York, New York, United States|
|Business Creation Center Salzburg||Austria, Salzburg|
|Changsha Lugu Hi-Tech Mobile Internet Venture Capital||Changsha, China, Jiangsu|
|Citi Alternative Investments||-|
|Emtek Group||Indonesia, Jakarta, Jakarta Raya|
|First Derivatives||Newry, Newry and Mourne, United Kingdom|
|Huarong Securities Shanghai Yanggao South Road Sales Department||China, Shanghai|
|LSS Private Equity||-|
|Neoforma||California, San Jose, United States|
|Panorama Capital||California, Campbell, United States|
|PJC Capital||Minneapolis, Minnesota, United States|
|Prudence Holdings||New York, New York, United States|
|Technicolor||California, United States, West Hollywood|
|Time Warner||New York, New York, United States|
|Yoshimei||Japan, Nara, Nara Prefecture|
|02 May 2022||London, England, United Kingdom|
|$11K||15 Mar 2022||Basel-Country, Switzerland|
|$7M||31 Dec 2021||Paris, Ile-de-France, France|
|$1M||03 Feb 2021||Barcelona, Catalonia, Spain|
|$1M||01 Dec 2020||Denmark, Region of Southern Denmark, Denmark|
Tympany Research Group
|$1M||19 Oct 2020||Galway, Galway, Ireland|
|$35K||03 Sep 2020||Barcelona, Catalonia, Spain|
|09 Jul 2020||Oxford, England, United Kingdom|
|$59K||26 Jun 2020||Zürich, Zurich, Switzerland|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.